# China NMPA Drug Inspection - Jiangxi Dongfeng Pharmaceutical Co., Ltd. - Xiao Chai Hu Granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/jiangxi-dongfeng-pharmaceutical-co-ltd/caf60374-0c25-4325-aa1f-4f34eb963444/
Source feed: China

> China NMPA drug inspection for Jiangxi Dongfeng Pharmaceutical Co., Ltd. published October 14, 2019. Drug: Xiao Chai Hu Granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 7, 2019) Announcement No. 16, 2019
- Company Name: Jiangxi Dongfeng Pharmaceutical Co., Ltd.
- Publication Date: 2019-10-14
- Drug Name: Xiao Chai Hu Granules
- Inspection Finding: [Inspection] Filling volume discrepancy does not meet regulations.
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/jiangxi-dongfeng-pharmaceutical-co-ltd/70ad8b50-1a56-44d6-9418-20a4526b62ae/
